Revised February 2018
Opioid-Related Overdose Deaths
In 2016, there were 154 opioid-related overdose deaths in Delaware—a rate of 16.9 deaths per 100,000 persons and more than the national rate of 13.3 deaths per 100,000 persons.
Opioid Pain Reliever Prescriptions
In 2015, providers in Delaware wrote 768,974 prescriptions for opioid pain relievers, or 80 prescriptions for every 100 persons. This was a 7.1 percent decline since 2013―compared to the average U.S. rate of 71 opioid prescriptions per 100 persons (IMS Health, 2016).
Neonatal Abstinence Syndrome (NAS)
According to hospital discharge data, during 2010 to 2013 in Delaware, 639 cases of NAS were identified with an incidence of 15.6 cases per 1,000 births. The incidence of NAS increased 56 percent, from 11.9 cases per 1,000 births in 2010 to 18.5 cases per 1,000 births in 2013. Delaware’s 2012 and 2013 NAS rates (17.8 and 18.5 cases per 1,000 births, respectively) were 3 times that of the 2012 average U.S. rate (5.8 cases per 1,000 births) (DE Health and Social Services).
HIV Prevalence and HIV Diagnoses Attributed to Injection Drug Use (IDU)
- U.S. Incidence: In 2015, 9.1 percent (3,5941) of the 39,513 new diagnoses of HIV in the United States were attributed to IDU. Among new cases, 8.2 percent (2,6141) of cases among men and 13.2 percent (980) of cases among women were transmitted via IDU (CDC).
- U.S. Prevalence: In 2014, 955,081 Americans were living with a diagnosed HIV infection—a rate of 299.5 per 100,000 persons. Of these, 18.1 percent (131,0561) of males and 22.6 percent (52,013) of females were living with HIV attributed to IDU (CDC).
- State Incidence: Of the new HIV cases in 2015, 109 occurred in Delaware, with 4.7 percent1 of new cases in males and 8.7 percent of new cases in females attributed to IDU (AIDSVu).
- State Prevalence: In 2014, an estimated 3,213 persons were living with a diagnosed HIV infection in Delaware—a rate of 407 per 100,000 persons. Of these, 25.7 percent1 of males and 26.3 percent of females were living with HIV attributed to IDU (AIDSVu).
Hepatitis C (HCV) Prevalence and HCV Diagnoses Attributed to Injection Drug Use
- U.S. Incidence: In 2015, there were 181,871 reported cases of chronic HCV and 33,900 estimated cases of acute HCV2 (CDC). Where data were available, 64.2 percent of acute cases reported IDU (CDC).
- U.S. Prevalence: An estimated 3.5 million Americans are living with HCV, including approximately 2.7 million living with chronic infections (CDC).
- State Incidence: In 2015, Delaware reported 31 cases of chronic HCV and 4 cases of acute HCV (0.4 per 100,000 persons) (CDC).
- State Prevalence: Current state prevalence data are not available. As of 2010, an estimated 13,600 (1,970 per 100,000) persons were living with HCV in Delaware (HepVu).
- Delaware Health and Social Services, The Delaware Opioid Epidemic
- Centers for Disease Control and Prevention, Opioid Overdose
- Centers for Disease Control and Prevention, Annual Surveillance Report of Drug-Related Risks and Outcomes (2017)
- Substance Abuse and Mental Health Services Administration, Behavioral Health Barometer Delaware, Volume 4 (2017)
- Includes transmission to individuals with injection drug use as a risk factor.
- 2015 estimate after adjusting for under-ascertainment and under-reporting. Data for 2015 were unavailable for Alaska, Arizona, Connecticut, the District of Columbia, Hawaii, Iowa, Mississippi, New Hampshire, Rhode Island, and Wyoming.
Emerging Trends & Alerts
Get more information on Emerging Trends and Alerts, we will update this page with the latest research findings as they develop.
Get this Publication
NIH HEAL (Helping to End Addiction Long-term) Initiative
New Opioid Overdose Materials for Patients
Find information about addiction and mental health services in your area. You can search by state or zip code online or call the number. (SAMHSA)